GlassScriptPhysician profile
Linsey Lindley
NPI 1912439720
$1,152.51
in general payments reported to CMS, 2019-2025
16 companies · $83.75 in 2025
The $83.75 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.78 · 2022: $228 · 2023: $447 · 2024: $340 · 2025: $83.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $546.83 | 2021-2024 | |
| Janssen Biotech, INC. | $139.09 | 2021-2023 | Tremfya |
| Lilly USA, LLC | $74.60 | 2021-2024 | Taltz, Olumiant, Ebglyss |
| Krystal Biotech INC | $64.71 | 2024-2025 | Vyjuvek |
| E.R. Squibb & Sons, L.L.C. | $64.27 | 2023-2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $42.38 | 2023 | Odomzo, Blu-U, Ilumya |
| Incyte Corporation | $35.84 | 2023-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $32.44 | 2023 | |
| Procept Biorobotics Corporation | $30.65 | 2023 | Aquabeam Robotic System |
| Leo Pharma INC. | $23.25 | 2023 | Adbry |
| Genzyme Corporation | $21.52 | 2023 | |
| Amgen INC. | $20.26 | 2025 | Otezla |
| Ucb, INC. | $16.22 | 2025 | Bimzelx |
| Pfizer INC. | $14.34 | 2022 | |
| Organon LLC | $13.37 | 2025 | Vtama |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.74 | 2023 | Spevigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linsey Lindley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.